Potentiation of liposome-induced complement activation by surface-bound albumin

Biochimica et Biophysica Acta - Biomembranes

Volumn 1559, Issue 1, 2002, Pages 79-86

  Savay, Sandor ^a   Szebeni, Janos ^a   Baranyi, Lajos ^a   Alving, Carl R ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Complement; Inflammation; Liposome; Natural antibody; Phospholipid bilayer; Polycarbonate membrane; Serum albumin

Indexed keywords

EGTAZIC ACID; FATTY ACID; HUMAN SERUM ALBUMIN; LIPOSOME; POLYCARBONATE; PROTEIN; S PROTEIN BOUND C5B 9; UNCLASSIFIED DRUG; ZYMOSAN;

ALBUMIN BLOOD LEVEL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; MEMBRANE; NORMAL HUMAN; PRIORITY JOURNAL; ULTRAFILTRATION;

CARBONATES; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; DRUG SYNERGISM; FATTY ACIDS, NONESTERIFIED; HUMANS; LIPOSOMES; SERUM ALBUMIN; SURFACE PROPERTIES;

EID: 0037050764     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(01)00408-4     Document Type: Article

References (24)

1. Interactions of liposomes with serum proteins
2. The role of immunoproteins in the survival of liposomes in the circulation
3. Influence of dose on liposome clearance: Critical role of blood proteins
4. Hydrophobic free energy, micelle formation and the association of proteins with amphiphiles
5. Activation of glucose diffusion from egg lecithin liquid crystals by serum albumin
6. Complement activation in vitro by the red blood cell substitute, liposome-encapsulated hemoglobin: Mechanism of activation and inhibition by soluble complement receptor type 1
7. Liposome-induced pulmonary hypertension: Properties and mechanism of a complement-mediated pseudoallergic reaction
8. The interaction of liposomes with the complement system
9. The use of albumin in clinical practice
10. Overview of the complement system
11. Interactions between polymerized human albumin, hepatitis B surface antigen, and complement: I. Binding of polyalbumin to Clq
12. Antibodies to cholesterol, cholesterol conjugates, and liposomes: Implications for atherosclerosis and autoimmunity
13. Complement activation in human serum by liposome-encapsulated hemoglobin: The role of natural anti-phospholipid antibodies
14. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: Beta 2-glycoprotein I (apolipoprotein H)
15. Studies on HBsAg binding with polymerised human serum albumin by ELISA
16. Antibodies specific for human albumin function as blocking antibodies when attached to erythrocyte-bound albumin
17. Blocking antibodies specific for human albumin interfere with the hemolytic activity of the membrane attack complex of complement
18. Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages
19. Human serum albumin as a probe for protein adsorption to nanoparticles: Relevance to biodistribution
20. Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: A possibility for antiviral drug targeting
21. Surface-modified biodegradable albumin nano- and microspheres. II: Effect of surface charges on in vitro phagocytosis and biodistribution in rats
22. 14C)-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats
23. Albumin nanospheres as carriers for passive drug targeting: An optimized manufacturing technique